Aptose Biosciences Inc. Annual Nonoperating Income (Expense) in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Aptose Biosciences Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2017 to 2023.
  • Aptose Biosciences Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $12K, a 94.9% decline year-over-year.
  • Aptose Biosciences Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $397K, a 71.2% decline year-over-year.
  • Aptose Biosciences Inc. annual Nonoperating Income (Expense) for 2023 was $1.15M, a 47.5% increase from 2022.
  • Aptose Biosciences Inc. annual Nonoperating Income (Expense) for 2022 was $779K, a 738% increase from 2021.
  • Aptose Biosciences Inc. annual Nonoperating Income (Expense) for 2021 was $93K, a 82.5% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.15M +$370K +47.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-26
2022 $779K +$686K +738% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-26
2021 $93K -$437K -82.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-24
2020 $530K -$50K -8.62% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-22
2019 $580K +$341K +143% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-23
2018 $239K +$56K +30.6% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-10
2017 $183K Jan 1, 2017 Dec 31, 2017 10-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.